-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Clemizole
Category | HCV Protease |
CAS | 442-52-4 |
Description | Clemizole is an H1 antagonist acts as a TRPC5 channel blocker (IC50 values are 1.1, 6.4, 9.1, 11.3 and 26.5 μM for TRPC5, TRPC4, TRPC3, TRPC6 and TRPC7 respectively). |
Product Information
Synonyms | Clemizole;442-52-4;Histacur;Clemizol;Histakool;1-(4-Chlorobenzyl)-2-(pyrrolidin-1-ylmethyl)-1H-benzo[d]imidazole;Clemizolum;Lergopenin;Depocural;1-[(4-chlorophenyl)methyl]-2-(pyrrolidin-1-ylmethyl)benzimidazole;1-(p-Chlorobenzyl)-2-pyrrolidylmethylenebenzimidazole;1-p-Chlorobenzyl-2-(1-pyrrolidinylmethyl)benzimidazole;NSC 46261;NSC-46261;AL-20 FREE BASE;CHEBI:52140;T97CB3796L;AL 20 [AS HYDROCHLORIDE];1H-Benzimidazole, 1-[(4-chlorophenyl)methyl]-2-(1-pyrrolidinylmethyl)-;Benzimidazole, 1-(p-chlorobenzyl)-2-(1-pyrrolidinylmethyl)-;1H-Benzimidazole, 1-((4-chlorophenyl)methyl)-2-(1-pyrrolidinylmethyl)-;Clemizolo;1-(4-chlorobenzyl)-2-(pyrrolidin-1-ylmethyl)-1H-benzimidazole;C19H20ClN3;Clemizolo [DCIT];Clemizole [INN:BAN];NCGC00015243-02;Clemizol [INN-Spanish];Clemizolum [INN-Latin];CAS-1163-36-6;UNII-T97CB3796L;EINECS 207-133-5;Clemizole (free base);CLEMIZOLE [INN];Clemizole (free base)?;CLEMIZOLE [MI];Prestwick0_000227;Prestwick1_000227;Prestwick2_000227;Prestwick3_000227;Lopac-C-5040;CLEMIZOLE [WHO-DD];Lopac0_000284;Oprea1_226569;SCHEMBL29938;BSPBio_000273;SPBio_002194;BPBio1_000301;CHEMBL1407943;DTXSID0046939;BDBM85747;GTPL10285;BCP07894;NSC_2782;NSC46261;1-[(4-Chlorophenyl)methyl]-2-(1-pyrrolidinylmethyl)-1H-benzimidazole;MFCD00051434;s6410;AKOS001631429;CCG-106577;CS-1481;SDCCGSBI-0050272.P003;NCGC00015243-01;NCGC00015243-03;NCGC00015243-04;NCGC00015243-05;NCGC00015243-06;NCGC00015243-07;NCGC00015243-11;NCGC00015243-20;NCGC00015243-21;NCGC00024376-03;AS-56130;CAS_442-52-4;DA-51956;HY-30234;SBI-0050272.P002;NS00005706;L000853;Q5131527;SR-01000000057-6;SR-01000000057-9;BRD-K04704168-003-03-6;BRD-K04704168-003-11-9;BRD-K04704168-003-14-3;F0902-3266;1-(4-CHLOROBENZYL)-2-PYRROLIDINOMETHYL-BENZIMIDAZOLE;Pyrrolidine, 1-[(1-p-chlorobenzyl-2-benzimidazolyl)methyl]-;1-(4-Chlorobenzyl)-2-(1-pyrrolidinylmethyl)-1H-benzimidazole #;1-[(4-Chlorophenyl)methyl]-2-(pyrrolidinylmethyl)-1H-benzimidazole;GX0; |
IUPAC Name | 1-[(4-chlorophenyl)methyl]-2-(pyrrolidin-1-ylmethyl)benzimidazole |
Molecular Weight | 325.84 |
Molecular Formula | C19H20ClN3 |
Canonical SMILES | ClC1=CC=C(C=C1)CN2C(CN3CCCC3)=NC4=CC=CC=C24 |
InChI | InChI=1S/C19H20ClN3/c20-16-9-7-15(8-10-16)13-23-18-6-2-1-5-17(18)21-19(23)14-22-11-3-4-12-22/h1-2,5-10H,3-4,11-14H2 |
InChIKey | CJXAEXPPLWQRFR-UHFFFAOYSA-N |
Boiling Point | 506.1°C at 760mmHg |
Purity | ≥95% |
Density | 1.25 g/cm3 |
Solubility | Soluble in DMSO |
Appearance | Solid |
Application | TRPC5 channel blocker |
Shelf Life | As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly |
Storage | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |